LBF17101HO01: Difference between revisions
No edit summary |
No edit summary |
||
| (10 intermediate revisions by 2 users not shown) | |||
| Line 6: | Line 6: | ||
|LipidBank=DFA8152 | |LipidBank=DFA8152 | ||
|LipidMaps=LMFA01050146 | |LipidMaps=LMFA01050146 | ||
|SysName= | |SysName=12S-Hydroxy-16-heptadecynoic acid | ||
|Common Name=&&12 (S) - | |Common Name=&&12(S) -Hydroxy-16-heptadecynoic acid&& | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Biological Activity= | |Biological Activity=12S-Hydroxy-16-heptadecynoic acid inhibits prostaglandin ω -hydroxylase with a K_i of 1.8 μ M [[Reference:Burger_A:Clark_JE:Nishimoto_M:Muerhoff_AS:Masters_BS:Ortiz_de_Montellano_PR:,J. Med. Chem.,1993,36,1418|{{RelationTable/GetFirstAuthor|Reference:Burger_A:Clark_JE:Nishimoto_M:Muerhoff_AS:Masters_BS:Ortiz_de_Montellano_PR:,J. Med. Chem.,1993,36,1418}}]]. | ||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Latest revision as of 02:52, 26 May 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8152 |
| LipidMaps | LMFA01050146 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF17101HO01 |
| 12(S) -Hydroxy-16-heptadecynoic acid | |
|---|---|
| |
| Structural Information | |
| 12S-Hydroxy-16-heptadecynoic acid | |
| |
| Formula | C17H30O3 |
| Exact Mass | 282.21949482599996 |
| Average Mass | 282.4183 |
| SMILES | C#CCCCC(O)CCCCCCCCCCC(O)=O |
| Physicochemical Information | |
| 12S-Hydroxy-16-heptadecynoic acid inhibits prostaglandin ω -hydroxylase with a K_i of 1.8 μ M Burger_A et al.. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
